Walleye Trading LLC Arvinas, Inc. Call Options Transaction History

Walleye Trading LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	SELL	$32.47 - $57.24 $19,482 - $34,344	-600 Reduced 13.95%	3,700 $126,000
Q3 2022 Nov 14, 2022	SELL	$41.87 - $57.99 $113,049 - $156,573	-2,700 Reduced 38.57%	4,300 $191,000
Q2 2022 Aug 08, 2022	BUY	$36.01 - $74.24 $158,444 - $326,656	4,400 Added 169.23%	7,000 $295,000
Q1 2022 May 16, 2022	BUY	$60.27 - $81.57 $156,702 - $212,081	2,600 New	2,600 $175,000
Q3 2021 Nov 15, 2021	SELL	$73.2 - $107.87 $285,480 - $420,693	-3,900 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$60.45 - $84.26 $132,990 - $185,372	2,200 Added 129.41%	3,900 $300,000
Q1 2021 May 17, 2021	SELL	$58.19 - $91.37 $87,285 - $137,055	-1,500 Reduced 46.88%	1,700 $112,000
Q4 2020 Feb 16, 2021	BUY	$20.19 - $84.93 $64,608 - $271,776	3,200 New	3,200 $272,000

229

68.4M

226K

285K

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $1.38B
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.